Case Report
Intestinal Type of Lung Adenocarcinoma in Younger Adults
Table 1
Panel of applied antibodies, their manufacturer, dilution, and reaction.
| | Number | Antibody and clone | Manufacturer | Dilution | Reaction |
| | 1 | Cytokeratin7; Clone OV-TL 12/30 | Dako | 1 : 50 | Cytoplasmatic | | 2 | Cytokeratin20; Clone Ks20.8 | Dako | 1 : 25 | Cytoplasmatic | | 3 | TTF-1; Clone 8G7G3/1 | Dako | 1 : 50 | Nuclear | | 4 | CDX-2; Clone: DAK-CDX2 | Dako | 1 : 50 | Nuclear | | 5 | Napsin-A; Clone: IP64 | Novocastra | 1 : 400 | Punctate cytoplasmatic | | 6 | Villin; Clone 1D2 C3 | Dako | 1 : 50 | Membranous and cytoplasmatic | | 7 | SurfactantB; Clone: 19H7 | Novocastra | 1 : 25 | Cytoplasmatic | | 8 | MUC-1; Clone: Ma695 | Novocastra | 1 : 100 | Cytoplasmatic | | 9 | MUC-2; Clone: Ccp58 | Novocastra | 1 : 100 | Cytoplasmatic |
|
|
